Synthroid
- Product NDC
- 0074-3727
- 11-digit product format
- 000743727
- Labeler code
- 0074
- Product ID
- 0074-3727_b85ab7fa-ba96-43cd-b736-44b3924e644c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Levothyroxine Sodium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- AbbVie Inc.
- Application
- NDA021402
- Marketing category
- NDA
- Marketing start
- 2002-07-24
- Substance
- LEVOTHYROXINE SODIUM
- Active strength
- 137 ug/1
- Pharmacologic classes
- Thyroxine [CS], l-Thyroxine [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 0074-3727 | 0074-3727-13 | D | Discontinued by firm | 2026-08-03 | |
| excluded package | package | 0074-3727 | 0074-3727-71 | D | Discontinued by firm | 2026-08-03 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | 0074-3727-71 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | 0074-3727-13 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 0074-3727-71 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 0074-3727-13 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 0074-3727-71 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 0074-3727-13 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 0074-3727-71 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 0074-3727-13 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 0074-3727-71 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 0074-3727-13 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 0074-3727-71 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 0074-3727-13 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 0074-3727-71 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 0074-3727-13 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 0074-3727-71 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 0074-3727-13 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 0074-3727-71 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 0074-3727-13 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 0074-3727-71 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 0074-3727-13 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 0074-3727-71 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 0074-3727-13 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 0074-3727-71 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 0074-3727-13 | 557ba5c1ecfa… | 9c80585c8c6e… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021402-001 | SYNTHROID | LEVOTHYROXINE SODIUM | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2 | RLD | 2002-07-24 |
| N021402-002 | SYNTHROID | LEVOTHYROXINE SODIUM | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2 | RLD | 2002-07-24 |
| N021402-003 | SYNTHROID | LEVOTHYROXINE SODIUM | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2 | RLD | 2002-07-24 |
| N021402-004 | SYNTHROID | LEVOTHYROXINE SODIUM | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2 | RLD | 2002-07-24 |
| N021402-005 | SYNTHROID | LEVOTHYROXINE SODIUM | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2 | RLD | 2002-07-24 |
| N021402-006 | SYNTHROID | LEVOTHYROXINE SODIUM | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2 | RLD | 2002-07-24 |
| N021402-007 | SYNTHROID | LEVOTHYROXINE SODIUM | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2 | RLD | 2002-07-24 |
| N021402-008 | SYNTHROID | LEVOTHYROXINE SODIUM | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2 | RLD | 2002-07-24 |
| N021402-009 | SYNTHROID | LEVOTHYROXINE SODIUM | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2 | RLD | 2002-07-24 |
| N021402-010 | SYNTHROID | LEVOTHYROXINE SODIUM | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2 | RLD | 2002-07-24 |
| N021402-011 | SYNTHROID | LEVOTHYROXINE SODIUM | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2 | RLD, RS | 2002-07-24 |
| N021402-012 | SYNTHROID | LEVOTHYROXINE SODIUM | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2 | RLD | 2002-07-24 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N021402-001 | AB1 |
| N021402-001 | AB2 |
| N021402-002 | AB1 |
| N021402-002 | AB2 |
| N021402-003 | AB1 |
| N021402-003 | AB2 |
| N021402-004 | AB1 |
| N021402-004 | AB2 |
| N021402-005 | AB1 |
| N021402-005 | AB2 |
| N021402-006 | AB1 |
| N021402-006 | AB2 |
| N021402-007 | AB1 |
| N021402-007 | AB2 |
| N021402-008 | AB1 |
| N021402-008 | AB2 |
| N021402-009 | AB1 |
| N021402-009 | AB2 |
| N021402-010 | AB1 |
| N021402-010 | AB2 |
| N021402-011 | AB1 |
| N021402-011 | AB2 |
| N021402-012 | AB1 |
| N021402-012 | AB2 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N021402-001 | SYNTHROID | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2 | RLD | 2002-07-24 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021402-002 | SYNTHROID | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2 | RLD | 2002-07-24 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021402-003 | SYNTHROID | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2 | RLD | 2002-07-24 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021402-004 | SYNTHROID | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2 | RLD | 2002-07-24 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021402-005 | SYNTHROID | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2 | RLD | 2002-07-24 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021402-006 | SYNTHROID | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2 | RLD | 2002-07-24 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021402-007 | SYNTHROID | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2 | RLD | 2002-07-24 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021402-008 | SYNTHROID | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2 | RLD | 2002-07-24 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021402-009 | SYNTHROID | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2 | RLD | 2002-07-24 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021402-010 | SYNTHROID | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2 | RLD | 2002-07-24 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021402-011 | SYNTHROID | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2 | RLD, RS | 2002-07-24 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021402-012 | SYNTHROID | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2 | RLD | 2002-07-24 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021402-001 | SYNTHROID | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2 | RLD | 2002-07-24 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021402-002 | SYNTHROID | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2 | RLD | 2002-07-24 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021402-003 | SYNTHROID | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2 | RLD | 2002-07-24 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021402-004 | SYNTHROID | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2 | RLD | 2002-07-24 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021402-005 | SYNTHROID | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2 | RLD | 2002-07-24 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021402-006 | SYNTHROID | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2 | RLD | 2002-07-24 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021402-007 | SYNTHROID | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2 | RLD | 2002-07-24 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021402-008 | SYNTHROID | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2 | RLD | 2002-07-24 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021402-009 | SYNTHROID | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2 | RLD | 2002-07-24 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021402-010 | SYNTHROID | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2 | RLD | 2002-07-24 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021402-011 | SYNTHROID | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2 | RLD, RS | 2002-07-24 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021402-012 | SYNTHROID | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2 | RLD | 2002-07-24 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N021402-001 | SYNTHROID | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2 | RLD | 2002-07-24 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021402-002 | SYNTHROID | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2 | RLD | 2002-07-24 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021402-003 | SYNTHROID | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2 | RLD | 2002-07-24 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021402-004 | SYNTHROID | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2 | RLD | 2002-07-24 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021402-005 | SYNTHROID | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2 | RLD | 2002-07-24 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021402-006 | SYNTHROID | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2 | RLD | 2002-07-24 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021402-007 | SYNTHROID | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2 | RLD | 2002-07-24 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021402-008 | SYNTHROID | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2 | RLD | 2002-07-24 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021402-009 | SYNTHROID | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2 | RLD | 2002-07-24 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021402-010 | SYNTHROID | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2 | RLD | 2002-07-24 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021402-011 | SYNTHROID | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2 | RLD, RS | 2002-07-24 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021402-012 | SYNTHROID | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2 | RLD | 2002-07-24 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021402-001 | SYNTHROID | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2 | RLD | 2002-07-24 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021402-002 | SYNTHROID | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2 | RLD | 2002-07-24 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021402-003 | SYNTHROID | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2 | RLD | 2002-07-24 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021402-004 | SYNTHROID | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2 | RLD | 2002-07-24 | fd3edfee7708… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N021402-001 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021402-001 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021402-002 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021402-002 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021402-003 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021402-003 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021402-004 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021402-004 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021402-005 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021402-005 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021402-006 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021402-006 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021402-007 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021402-007 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021402-008 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021402-008 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021402-009 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021402-009 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021402-010 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021402-010 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021402-011 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021402-011 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021402-012 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021402-012 | AB2 | 2 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021402-001 | AB1 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021402-001 | AB2 | 2 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021402-002 | AB1 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021402-002 | AB2 | 2 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021402-003 | AB1 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021402-003 | AB2 | 2 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021402-004 | AB1 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021402-004 | AB2 | 2 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021402-005 | AB1 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021402-005 | AB2 | 2 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021402-006 | AB1 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021402-006 | AB2 | 2 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021402-007 | AB1 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021402-007 | AB2 | 2 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021402-008 | AB1 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021402-008 | AB2 | 2 | 31067a03dcf5… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Synthroid
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| LEVOTHYROXINE SODIUM | 137 ug/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 9J765S329G | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 892246 | Internal RxNorm lookup |
| 892251 | Internal RxNorm lookup |
| 892255 | Internal RxNorm lookup |
| 966158 | Internal RxNorm lookup |
| 966171 | Internal RxNorm lookup |
| 966185 | Internal RxNorm lookup |
| 966191 | Internal RxNorm lookup |
| 966201 | Internal RxNorm lookup |
| 966205 | Internal RxNorm lookup |
| 966218 | Internal RxNorm lookup |
| 966220 | Internal RxNorm lookup |
| 966221 | Internal RxNorm lookup |
| 966222 | Internal RxNorm lookup |
| 966224 | Internal RxNorm lookup |
| 966225 | Internal RxNorm lookup |
| 966247 | Internal RxNorm lookup |
| 966248 | Internal RxNorm lookup |
| 966249 | Internal RxNorm lookup |
| 966250 | Internal RxNorm lookup |
| 966251 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1e11ad30-1041-4520-10b0-8f9d30d30fcc | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 97c252d3-9bb8-4530-bb44-9824dc7cf556 | Product name | 6 | 20250729 |
| 6c43b71c-35e6-4db3-ba24-c6ef42ff7003 | Product name | 3 | 20240207 |
| 890fd4bf-1a80-42b7-be1b-2d0259d5f0c8 | Product name | 5 | 20240207 |
| c8ad26bf-af73-460b-b74e-1eff16cc4f9f | Product name | 5 | 20240207 |
| 594e2c86-3079-4e6e-96c9-48f7a8afc78d | Product name | 1 | 20230718 |
| 01383843-4069-43cf-aa76-dc17a6f9f8c4 | Product name | 2 | 20230123 |
| 978cca7d-a938-4791-8322-da48d90a63ef | Product name | 1 | 20230113 |
| 65f86ba3-8816-4e12-899b-18290c8de551 | Product name | 2 | 20210614 |
| f16ab90f-08c2-40be-a543-66d9827cd1f3 | Product name | 1 | 20210601 |
| 6a33ec05-2ae2-45e5-ab82-2d94b3303923 | Product name | 1 | 20190709 |
| 93355a10-1c44-4c92-a11d-7d995e0200d9 | Product name | 1 | 20190219 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0074-3727-13 | Synthroid | 100 in 1 BOTTLE | TABLET | 100 | 1537 | |
| 0074-3727-19 | Synthroid | 1000 in 1 BOTTLE | TABLET | 1000 | 1537 | |
| 0074-3727-71 | Synthroid | 4 in 1 CARTON | TABLET | 4 | 1537 | |
| 0074-3727-71 | Synthroid | 7 in 1 BLISTER PACK | TABLET | 7 | 1537 | |
| 0074-3727-72 | Synthroid | 7 in 1 BLISTER PACK | TABLET | 7 | 1537 | |
| 0074-3727-72 | Synthroid | 2 in 1 CARTON | TABLET | 2 | 1537 | |
| 0074-3727-90 | Synthroid | 90 in 1 BOTTLE | TABLET | 90 | 1537 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0074-3727-19 | EA - Each | 0074-3727 | d3287b1c-440a-4b0d-af48-8d4145d1b5bb | 1 | 2015-07-20 |
| 0074-3727-90 | EA - Each | 0074-3727 | 3d2cdca2-c96b-4a3f-9c3e-d1e9bba5a9f8 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Synthroid | LEVOTHYROXINE SODIUM | AbbVie Inc. | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 2024-02-20 | Boxed warning, Warnings, Adverse reactions | 021402 NDA021402 0074-3727 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 892246 | levothyroxine sodium 100 MCG Oral Tablet | PSN | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966248 | levothyroxine sodium 112 MCG Oral Tablet | PSN | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966224 | levothyroxine sodium 125 MCG Oral Tablet | PSN | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966270 | levothyroxine sodium 137 MCG Oral Tablet | PSN | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966225 | levothyroxine sodium 150 MCG Oral Tablet | PSN | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966249 | levothyroxine sodium 175 MCG Oral Tablet | PSN | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 892251 | levothyroxine sodium 200 MCG Oral Tablet | PSN | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966220 | levothyroxine sodium 25 MCG Oral Tablet | PSN | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 892255 | levothyroxine sodium 300 MCG Oral Tablet | PSN | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966221 | levothyroxine sodium 50 MCG Oral Tablet | PSN | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966222 | levothyroxine sodium 75 MCG Oral Tablet | PSN | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966253 | levothyroxine sodium 88 MCG Oral Tablet | PSN | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966250 | SYNTHROID 100 MCG Oral Tablet | PSN | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966185 | SYNTHROID 112 MCG Oral Tablet | PSN | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966191 | SYNTHROID 125 MCG Oral Tablet | PSN | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966271 | SYNTHROID 137 MCG Oral Tablet | PSN | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966201 | SYNTHROID 150 MCG Oral Tablet | PSN | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966205 | SYNTHROID 175 MCG Oral Tablet | PSN | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966251 | SYNTHROID 200 MCG Oral Tablet | PSN | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966158 | SYNTHROID 25 MCG Oral Tablet | PSN | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966218 | SYNTHROID 300 MCG Oral Tablet | PSN | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966247 | SYNTHROID 50 MCG Oral Tablet | PSN | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966171 | SYNTHROID 75 MCG Oral Tablet | PSN | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966282 | SYNTHROID 88 MCG Oral Tablet | PSN | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966158 | levothyroxine sodium 0.025 MG Oral Tablet [Synthroid] | SBD | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966247 | levothyroxine sodium 0.05 MG Oral Tablet [Synthroid] | SBD | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966171 | levothyroxine sodium 0.075 MG Oral Tablet [Synthroid] | SBD | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966282 | levothyroxine sodium 0.088 MG Oral Tablet [Synthroid] | SBD | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966250 | levothyroxine sodium 0.1 MG Oral Tablet [Synthroid] | SBD | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966185 | levothyroxine sodium 0.112 MG Oral Tablet [Synthroid] | SBD | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966191 | levothyroxine sodium 0.125 MG Oral Tablet [Synthroid] | SBD | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966271 | levothyroxine sodium 0.137 MG Oral Tablet [Synthroid] | SBD | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966201 | levothyroxine sodium 0.15 MG Oral Tablet [Synthroid] | SBD | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966205 | levothyroxine sodium 0.175 MG Oral Tablet [Synthroid] | SBD | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966251 | levothyroxine sodium 0.2 MG Oral Tablet [Synthroid] | SBD | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966218 | levothyroxine sodium 0.3 MG Oral Tablet [Synthroid] | SBD | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966220 | levothyroxine sodium 0.025 MG Oral Tablet | SCD | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966221 | levothyroxine sodium 0.05 MG Oral Tablet | SCD | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966222 | levothyroxine sodium 0.075 MG Oral Tablet | SCD | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966253 | levothyroxine sodium 0.088 MG Oral Tablet | SCD | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 892246 | levothyroxine sodium 0.1 MG Oral Tablet | SCD | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966248 | levothyroxine sodium 0.112 MG Oral Tablet | SCD | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966224 | levothyroxine sodium 0.125 MG Oral Tablet | SCD | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966270 | levothyroxine sodium 0.137 MG Oral Tablet | SCD | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966225 | levothyroxine sodium 0.15 MG Oral Tablet | SCD | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966249 | levothyroxine sodium 0.175 MG Oral Tablet | SCD | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 892251 | levothyroxine sodium 0.2 MG Oral Tablet | SCD | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 892255 | levothyroxine sodium 0.3 MG Oral Tablet | SCD | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 892246 | levothyroxine sodium 100 MCG Oral Tablet | SY | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966248 | levothyroxine sodium 112 MCG Oral Tablet | SY | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966224 | levothyroxine sodium 125 MCG Oral Tablet | SY | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966270 | levothyroxine sodium 137 MCG Oral Tablet | SY | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966225 | levothyroxine sodium 150 MCG Oral Tablet | SY | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966249 | levothyroxine sodium 175 MCG Oral Tablet | SY | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 892251 | levothyroxine sodium 200 MCG Oral Tablet | SY | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966220 | levothyroxine sodium 25 MCG Oral Tablet | SY | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 892255 | levothyroxine sodium 300 MCG Oral Tablet | SY | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966221 | levothyroxine sodium 50 MCG Oral Tablet | SY | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966222 | levothyroxine sodium 75 MCG Oral Tablet | SY | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966253 | levothyroxine sodium 88 MCG Oral Tablet | SY | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966158 | Synthroid 0.025 MG Oral Tablet | SY | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966247 | Synthroid 0.05 MG Oral Tablet | SY | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966171 | Synthroid 0.075 MG Oral Tablet | SY | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966282 | Synthroid 0.088 MG Oral Tablet | SY | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966250 | Synthroid 0.1 MG Oral Tablet | SY | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966185 | Synthroid 0.112 MG Oral Tablet | SY | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966191 | Synthroid 0.125 MG Oral Tablet | SY | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966271 | Synthroid 0.137 MG Oral Tablet | SY | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966201 | Synthroid 0.15 MG Oral Tablet | SY | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966205 | Synthroid 0.175 MG Oral Tablet | SY | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966251 | Synthroid 0.2 MG Oral Tablet | SY | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966218 | Synthroid 0.3 MG Oral Tablet | SY | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966250 | Synthroid 100 MCG Oral Tablet | SY | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966185 | Synthroid 112 MCG Oral Tablet | SY | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966191 | Synthroid 125 MCG Oral Tablet | SY | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966271 | Synthroid 137 MCG Oral Tablet | SY | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966201 | Synthroid 150 MCG Oral Tablet | SY | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966205 | Synthroid 175 MCG Oral Tablet | SY | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966251 | Synthroid 200 MCG Oral Tablet | SY | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
| 966158 | Synthroid 25 MCG Oral Tablet | SY | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 1537 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 0074-3727-13 | 00074372713 | 100 in 1 BOTTLE | Historical | |||||
| 0074-3727-19 | 00074372719 | 1000 TABLET in 1 BOTTLE (0074-3727-19) | 1000 tablet | 2002-07-24 | 0000-00-00 | No | No | Current |
| 0074-3727-71 | 00074372771 | 4 in 1 CARTON | Historical | |||||
| 0074-3727-72 | 00074372772 | 2 BLISTER PACK in 1 CARTON (0074-3727-72) / 7 TABLET in 1 BLISTER PACK | 2 blister pack | 2002-07-24 | 0000-00-00 | Yes | No | Current |
| 0074-3727-90 | 00074372790 | 90 TABLET in 1 BOTTLE (0074-3727-90) | 90 tablet | 2002-07-24 | 0000-00-00 | No | No | Current |